Abdominal Aortic Aneurysm (AAA) Repair Devices Market Size, Share, Trend, Industry Analysis Report By Product Type (Endovascular Stent Graft System, Synthetic Graft System, Others), By Site, By End Use, By Region – Market Forecast, 2025–2034
- Published Date:Jul-2025
- Pages: 129
- Format: PDF
- Report ID: PM5909
- Base Year: 2024
- Historical Data: 2020-2023
Market Overview
The global abdominal aortic aneurysm (AAA) repair devices market size was valued at USD 2.66 billion in 2024 and is projected to register a CAGR of 5.0% from 2025 to 2034. A rising aging demographic is experiencing higher instances of aortic wall degeneration, elevating the risk of aneurysms. This growing patient pool is increasing the demand for both elective and emergency AAA repair procedures.
The abdominal aortic aneurysm repair devices market encompasses the production and commercialization of medical devices used to treat weakened and enlarged sections of the abdominal aorta. These include stent grafts, catheters, guidewires, and ancillary tools designed for both open surgical repair (OSR) and endovascular aneurysm repair (EVAR). The market is driven by the rising adoption of minimally invasive surgery. EVAR is becoming the preferred treatment method due to shorter recovery times, reduced hospital stays, and lower procedural risks. This shift is fueling the demand for advanced stent grafts and imaging-guided delivery systems.
-repair-devices-market-size-by-region-2020-2034.png)
To Understand More About this Research: Request a Free Sample Report
New-generation stent grafts offer better conformability, durability, and anchoring mechanisms, reducing complications such as endoleaks and migration. These innovations are expanding the eligible patient population and improving long-term success rates. Moreover, public health initiatives and targeted screening for at-risk populations, especially men aged 65 and above, are enabling early detection. Early diagnosis significantly boosts elective repair rates, driving procedural volume.
Market Dynamics
Rising Incidence of Abdominal Aortic Aneurysm in Aging Population
Older adults are more prone to vascular degeneration due to the natural loss of elasticity in blood vessel walls, making them particularly vulnerable to aneurysm development. The rising life expectancy across many regions is expanding the elderly population, leading to an increase in the number of patients diagnosed with abdominal aortic aneurysms. Medical guidelines often recommend regular screening for aneurysms in individuals aged 65 and above, particularly those with a history of smoking or cardiovascular disease. This demographic shift is contributing to higher procedural volumes for minimally invasive and surgical repairs. The aging population continues to be a key driver for advancements in device safety, durability, and procedural success rates.
Increasing Burden of Hypertension and Smoking
Smoking, hypertension, obesity, and high cholesterol levels are among the leading contributors to the formation and progression of abdominal aortic aneurysms. According to the Centers for Disease Control and Prevention (CDC), from 2021 to 2023, the obesity prevalence in the U.S. adults was 40.3%, with no significant differences by gender. Adults aged 40 to 59 had higher rates than those aged 20 to 39 and 60 or older. These risk factors weaken the arterial wall over time, increasing the likelihood of aneurysmal dilation. The growing prevalence of these conditions across different age groups, especially among males over 60, has led to a consistent rise in diagnosed AAA cases. This trend is placing greater emphasis on early screening and preventive care, thereby increasing the number of individuals eligible for repair procedures. Healthcare providers are focusing on managing these underlying risks more proactively, which, in turn, is accelerating the demand for both elective and urgent aneurysm repair solutions in clinical settings.
-repair-devices-market-size-worth-usd-4.33-billion-by-2034.png)
Segment Insights
Product Type Analysis
Based on product type, the segmentation includes endovascular stent graft system, synthetic graft system, and others. In 2024, the endovascular stent graft system segment accounted for the largest revenue share due to the increased adoption of minimally invasive techniques that allow for quicker recovery, reduced surgical trauma, and shorter hospital stays. Technological advancements in stent design, leading to better flexibility, enhanced sealing, and improved delivery systems, make these devices suitable for a broader range of anatomies. Surgeons are increasingly favoring endovascular aneurysm repair (EVAR) over open surgery, particularly in elderly or high-risk patients, leading to strong procedural demand and widespread clinical adoption.
The synthetic graft system segment is expected to grow steadily in the coming years, due to its continued use in open surgical repair, particularly in complex or ruptured aneurysms where EVAR is not feasible. Surgeons may prefer synthetic grafts for their durability and compatibility in cases requiring direct aortic reconstruction. Although EVAR is gaining dominance, synthetic grafts remain essential in healthcare settings lacking EVAR capabilities or when patient anatomy is unsuitable for stent grafting. Emerging materials and surgical techniques are also expected to improve outcomes, maintaining relevance for synthetic grafts during the forecast period.
Site Analysis
Based on site, the segmentation includes infrarenal and pararenal. In 2024, the infrarenal segment accounted for a larger revenue share due to its high prevalence among AAA cases, making it the most commonly treated site. Infrarenal aneurysms are more accessible for both open and endovascular repair techniques, allowing broader clinical management. The availability of targeted stent graft designs and standardized surgical approaches for infrarenal repair further contributes to the segment’s dominance in procedural volumes.
The pararenal segment is projected to register a significant growth over the forecast period due to the adoption of technological advancements enabling more complex stent graft placements and fenestrated grafts tailored for anatomically challenging cases. The growing confidence in treating juxtarenal and pararenal aneurysms through advanced endovascular solutions is driving increased usage. Improved imaging and surgical navigation tools are also supporting this trend, leading to higher adoption rates in tertiary and specialized care centers.
End Use Analysis
Based on end use, the segmentation includes hospitals, ambulatory surgery centers, and clinics. In 2024, the hospitals segment accounted for the largest revenue share due to their comprehensive infrastructure, skilled vascular teams, and ability to handle both elective and emergency aneurysm procedures. Most high-risk or complex AAA cases are referred to hospital settings, where intensive monitoring and surgical backup are readily available. High patient footfall, access to advanced surgical tools, and integrated post-operative care contribute to hospitals being the dominant end-use channel in this market.
The ambulatory surgery centers segment is projected to register the highest CAGR during the forecast period due to growing preference for minimally invasive EVAR procedures that can be performed on an outpatient basis. Lower procedural costs, quicker discharge times, and rising patient comfort with non-hospital surgical care are accelerating this transition. Innovations in device miniaturization and streamlined procedural protocols are also enabling more AAA interventions to shift toward ambulatory care settings.
-repair-devices-market-by-source-analysis-2020-2034.png)
Regional Analysis
In 2024, the North America abdominal aortic aneurysm repair devices market accounted for the largest revenue share due to strong clinical adoption of endovascular aneurysm repair (EVAR) across hospitals and outpatient surgical centers. High awareness among at-risk populations, supported by widespread AAA screening programs and advanced diagnostic infrastructure, has accelerated early detection and intervention. Favorable reimbursement frameworks and the presence of experienced vascular specialists have also contributed to greater procedural volume. The availability of next-generation stent grafts and minimally invasive devices has further boosted market penetration, especially in treating high-risk elderly patients. Continued emphasis on clinical guidelines and patient-centric care models supports procedural standardization and reinforcing regional leadership in AAA repair.
U.S. Abdominal Aortic Aneurysm Repair Devices Market Trends
The abdominal aortic aneurysm repair devices market in the U.S. accounted for the largest revenue share in 2024 due to the high burden of cardiovascular risk factors and aging population demographics. According to the Population Reference Bureau, the U.S. demographic of individuals aged 65 and above is anticipated to grow significantly from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. This demographic trend is increasing the demand for timely diagnosis and advanced treatment solutions. Expanding Medicare coverage for preventive screenings and elective EVAR procedures has strengthened patient access. Frequent innovation cycles among domestic device manufacturers have resulted in rapid clinical adoption of advanced graft systems with improved sealing and navigation. Strong investments in vascular surgery training and interventional capabilities across urban and suburban centers ensure consistent procedural growth. The market also benefits from rigorous regulatory oversight that fosters trust and safety in device performance, enhancing overall treatment outcomes and driving revenue expansion.
Asia Pacific Abdominal Aortic Aneurysm Repair Devices Market Overview
The abdominal aortic aneurysm repair devices market in Asia Pacific is expected to register the highest CAGR of 11.35% from 2025 to 2034, due to increased awareness of vascular health, rising adoption of minimally invasive surgeries, and rapid expansion of specialized care facilities. Health systems in emerging economies are scaling up screening programs, and regional governments are actively supporting infrastructure development in vascular surgery. Medical tourism in key countries is also boosting the demand for advanced repair devices. Availability of cost-effective stent graft systems tailored to local patient populations is supporting wider accessibility. The influx of international medical device companies and their strategic partnerships in the region further accelerates the diffusion of innovation and standardization of endovascular interventions.
Europe Abdominal Aortic Aneurysm Repair Devices Market Assessment
The abdominal aortic aneurysm repair devices market in Europe registers significant growth, driven by a mature healthcare system, strong public funding, and growing preference for minimally invasive aortic repair devices. The increasing prevalence of lifestyle-related vascular diseases and the widespread implementation of surveillance programs have elevated procedural volumes across the region. Robust clinical research activity and collaborations between hospitals and manufacturers have led to early adoption of new-generation EVAR technologies. Countries with high aging populations are particularly contributing to market growth through higher intervention rates. Surgeons across Europe continue to expand indications for endovascular repair, supported by improved imaging systems, navigation tools, and custom-fitted graft technologies.
UK Abdominal Aortic Aneurysm Repair Devices Market Outlook
The abdominal aortic aneurysm repair devices market in the UK is growing due to rising demand for minimally invasive vascular procedures and advancements in imaging technologies. Increased awareness of abdominal aortic aneurysms through national screening programs has improved early detection rates, enabling timely intervention using endovascular repair devices. The National Health Service (NHS) continues to prioritize aneurysm management, allocating funds toward the development of updated surgical units and the acquisition of modern equipment. The availability of trained vascular specialists and improved hospital infrastructure further supports the adoption of stent graft systems over open surgery. Favorable reimbursement policies and a structured healthcare delivery model contribute to consistent procedural volumes. Local clinical trials and academic partnerships are encouraging the adoption of next-generation devices. Additionally, the aging population and growing incidence of lifestyle-related risk factors such as smoking and hypertension are contributing to a steady rise in the patient pool, making the UK an attractive market for global and regional manufacturers.
-repair-devices-market-trends-by-region-2020-2034.png)
Key Players and Competitive Analysis
The competitive landscape of the abdominal aortic aneurysm repair devices market is shaped by continuous innovation, clinical performance differentiation, and aggressive commercialization strategies. Industry analysis reveals a strong emphasis on expanding minimally invasive portfolios, particularly endovascular stent graft systems with advanced sealing, flexibility, and anatomical customization. Market expansion strategies include geographic diversification and portfolio extension through strategic alliances, licensing agreements, and co-development initiatives. Leading players are prioritizing mergers and acquisitions to strengthen their vascular product lines, achieve post-merger integration synergies, and leverage combined distribution networks. Technology advancements such as fenestrated grafts, low-profile delivery systems, and imaging-guided deployment tools are redefining procedural success rates and device adoption. Joint ventures between med-tech companies and academic centers are accelerating clinical trials and next-generation product development. Regulatory clearance of novel repair technologies is intensifying competition, pushing stakeholders to invest in physician training and digital engagement platforms. The market remains highly dynamic, requiring continuous adaptation to evolving surgical practices and reimbursement environments.
List of Key Companies
- Cardinal Health
- Cook
- Endologix LLC
- Gore Medical (W. L. Gore & Associates)
- JOTEC (Cryolife, Inc.)
- Lombard Medical
- Medtronic
- MicroPort Scientific Corporation
- Terumo Corporation
Abdominal Aortic Aneurysm Repair Devices Industry Development
In July 2024, Endoron Medical, a medtech company focused on endograft stapling solutions for abdominal aortic aneurysms, announced the closing of its USD 10 million Series A funding round, led by Sofinnova Partners, with contributions from the European Innovation Council Fund.
Abdominal Aortic Aneurysm Repair Devices Market Segmentation
By Product Type Outlook (Revenue USD Billion, 2020–2034)
- Endovascular Stent Graft System
- Synthetic Graft System
- Others
By Site Outlook (Revenue USD Billion, 2020–2034)
- Infrarenal
- Pararenal
By End Use Outlook (Revenue USD Billion, 2020–2034)
- Hospitals
- Ambulatory Surgery Centers
- Clinics
By Regional Outlook (Revenue USD Billion, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Abdominal Aortic Aneurysm Repair Devices Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2024 |
USD 2.66 billion |
|
Market Size in 2025 |
USD 2.79 billion |
|
Revenue Forecast by 2034 |
USD 4.33 billion |
|
CAGR |
5.0% from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020–2023 |
|
Forecast Period |
2025–2034 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global market size was valued at USD 2.66 billion in 2024 and is projected to grow to USD 4.33 billion by 2034.
The global market is projected to register a CAGR of 5.0% during the forecast period.
In 2024, the North America abdominal aortic aneurysm repair devices market accounted for the largest revenue share due to strong clinical adoption of endovascular aneurysm repair (EVAR) across hospitals and outpatient surgical centers.
A few of the key players are Medtronic, Endologix LLC, Gore Medical (W. L. Gore & Associates), MicroPort Scientific Corporation, Cook, JOTEC (Cryolife, Inc.), Cardinal Health, Terumo Corporation, and Lombard Medical.
In 2024, the endovascular stent graft system segment accounted for the largest revenue share due to increased adoption of minimally invasive techniques that allow for quicker recovery, reduced surgical trauma, and shorter hospital stays.
In 2024, the infrarenal segment accounted for a larger revenue share due to its high prevalence among AAA cases, making it the most commonly treated site.
© 2025 Polaris Market Research and Consulting. All rights reserved
